Cite
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
MLA
Meca-Lallana, J. E., et al. “Four-Year Safety and Effectiveness Data from Patients with Multiple Sclerosis Treated with Fingolimod: The Spanish GILENYA Registry.” PloS One, vol. 16, no. 10, Oct. 2021, p. e0258437. EBSCOhost, https://doi.org/10.1371/journal.pone.0258437.
APA
Meca-Lallana, J. E., Oreja-Guevara, C., Muñoz, D., Olascoaga, J., Pato, A., Ramió-Torrentà, L., Meca-Lallana, V., Hernández, M. A., Marzo, M. E., Álvarez-Cermeño, J. C., Rodríguez-Antigüedad, A., Montalbán, X., & Fernández, O. (2021). Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry. PloS One, 16(10), e0258437. https://doi.org/10.1371/journal.pone.0258437
Chicago
Meca-Lallana, J E, C Oreja-Guevara, D Muñoz, J Olascoaga, A Pato, L Ramió-Torrentà, V Meca-Lallana, et al. 2021. “Four-Year Safety and Effectiveness Data from Patients with Multiple Sclerosis Treated with Fingolimod: The Spanish GILENYA Registry.” PloS One 16 (10): e0258437. doi:10.1371/journal.pone.0258437.